Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
Jul 5 NVO Study links GLP-1 drugs, metformin to lower risk of certain cancers
Jul 5 NVO Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Jul 5 LLY Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
Jul 5 NVO Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
Jul 5 LLY Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Jul 5 LLY Eli Lilly Remains an Equities Outlier
Jul 5 NVO Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
Jul 5 ASND Pendopharm and Ascendis to distribute hypoparathyroidism treatment
Jul 5 LLY Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
Jul 5 NVO Is It Too Late to Buy Novo Nordisk Stock?
Jul 5 NVO Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
Jul 5 ASND Macy's, Ascendis Pharma And 3 Stocks To Watch Heading Into Friday
Jul 4 LLY Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
Jul 4 ASND Pendopharm signs distribution agreement with Ascendis Pharma for TransCon PTH in Canada
Jul 4 ASND Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada
Jul 4 NVO Novo Nordisk: Buy On Dips
Jul 4 LLY NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Jul 4 NVO NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Jul 4 LLY Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
Jul 4 LLY FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags